Actualités Apr 17, 2024 Addex Therapeutics lance la spin-off Neurosterix à Genève avec un investissement de USD 63 millions La société genevoise Addex Therapeutics s’est associée à Perceptive Advisors pour lancer la spin-off Neurosterix, un nouvel acteur dans le dévelo...
Evento S-GE Fattori chiave di successo per fare affari in Giappone Apr 23, 2024 10:15–12:10 Zürich 스위스
Événements S-GE Facteurs de succès clés pour faire des affaires au Japon Apr 23, 2024 10:15–12:10 Zürich 스위스
Event S-GE Schlüssel zum Erfolg: Strategische Faktoren für Geschäftsaktivitäten in Japan Apr 23, 2024 10:15–12:10 Zürich 스위스
News Mar 13, 2024 PSI developing new cancer therapy Researchers from the Paul Scherrer Institute (PSI) have developed a radiopharmaceutical to combat metastatic neuroendocrine tumors. After having ...
News Apr 23, 2024 BGG from China opens headquarters in Basel BGG is establishing new global headquarters in Basel, from which it plans to grow in Europe and the USA. The Beijing-based company is a supplier ...
News Jan 10, 2024 The remarkable chemical-pharmaceutical industry in the canton of Valais For decades, the canton of Valais has cultivated a reputation for excellence in the chemical and pharmaceutical industries, combining innovation ...
News Dec 19, 2023 Top Stories from Western Switzerland (October-December 2023) From achieving top rankings in global innovation to making significant advancements in healthcare and technology, discover Western Switzerland's ...
Aktuell Oct 19, 2023 Forschende kehren Therapieresistenz bei Prostatakrebs um Forschende des Instituts für Onkologische Forschung (IOR) haben herausgefunden, wodurch Therapieresistenzen bei Prostatakrebs umgekehrt werden kö...
News Apr 17, 2024 Addex Therapeutics launches spin-off Neurosterix in Geneva with USD 63 million investment Geneva's Addex Therapeutics has teamed up with Perceptive Advisors to launch spin-off Neurosterix, a new player in neurology-focused drug develop...
Actualités Aug 14, 2023 L’écosystème florissant de Berne pour l’innovation en sciences de la vie Au cœur de la Suisse occidentale, le canton de Berne s'est imposé comme une destination de choix pour les entreprises du secteur des sciences de ...
News May 10, 2022 Michael J. Fox Foundation awards Asceneuron a grant to treat Parkinson’s disease Committed to accelerating research into novel Parkinson’s Disease therapies, The Michael J. Fox Foundation for Parkinson’s Research is again awar...
Aktuell Oct 18, 2022 KetoSwiss erhöht Kapital um 4 Millionen Dollar KetoSwiss hat von Investoren 4 Millionen Dollar erhalten. Das Basler Start-up entwickelt Produkte zur Linderung neurologischer Erkankungen wie Mi...
News Sep 29, 2023 Top Stories from Western Switzerland (July-September 2023) From spearheading eco-innovative solutions to pioneering breakthroughs in solar technology, cancer research, sustainable shipping, and the realms...
News Oct 19, 2023 Researchers reverse prostate cancer therapy resistance Researchers at the Institute of Oncology Research (IOR) have discovered how to reverse prostate cancer therapy resistance. This advancement came ...
News Oct 18, 2023 BioArk Monthey’s third building signifies exponential growth in the life sciences sector With two decades under its belt, the BioArk site in Monthey continues to cement its position as a front-runner in life sciences.
News Nov 12, 2021 Bachem lays foundation stone for production building Bachem has laid the foundation stone for its largest production building to date. The company specializing in the manufacture of peptides and oli...